Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2008

01-03-2008 | Original Paper

Liver Regeneration in Donors Evaluated by Tc-99m-GSA Scintigraphy after Living Donor Liver Transplantation

Authors: Masaki Kaibori, Sang Kil Ha-Kawa, Yoichiro Uchida, Morihiko Ishizaki, Takamichi Saito, Kosuke Matsui, Junko Hirohara, Koichi Tanaka, Yasuo Kamiyama

Published in: Digestive Diseases and Sciences | Issue 3/2008

Login to get access

Abstract

The impact of hepatic steatosis on regeneration of the remnant liver after living donor liver transplantation is unclear. We evaluated the impact of steatosis on regeneration and function of the remnant liver by using technetium-99m-diethylenetriaminepentaacetic acid-galactosyl human serum albumin scintigraphy. Twelve living donors were classified into groups with or without mild hepatic steatosis according to the liver-to-spleen attenuation ratio on computed tomography: 6 donors had a ratio ≥ 1.20 (control group) and 6 donors had a ratio < 1.20 (fatty liver group). Scintigraphy was performed to determine the hepatic uptake ratio of the tracer (corrected for disappearance from the blood) and the maximum removal rate of the tracer by hepatocytes as parameters of the hepatic functional reserve. The fatty liver group had a significantly lower corrected hepatic uptake ratio and removal rate compared with the control group at 6 and 12 months after partial hepatectomy. These parameters were decreased at 1 month after surgery in both groups. However, both parameters returned more rapidly to prehepatectomy levels in the control group. The regenerated liver volume estimated by scintigraphy did not differ significantly between the two groups at any time. Liver scintigraphy may be useful for evaluating the regeneration of functioning hepatocytes. Because donors with mild hepatic steatosis showed impaired liver regeneration at 1 year after partial hepatectomy, management of these donors requires more care.
Literature
1.
go back to reference Burgess JB, Baenziger JU, Brown WR (1992) Abnormal surface distribution of the human asialoglycoprotein receptor in cirrhosis. Hepatology 15:702PubMedCrossRef Burgess JB, Baenziger JU, Brown WR (1992) Abnormal surface distribution of the human asialoglycoprotein receptor in cirrhosis. Hepatology 15:702PubMedCrossRef
2.
go back to reference Ha-Kawa SK, Tanaka Y, Hasebe S et al (1997) Compartmental analysis of asialoglycoprotein receptor scintigraphy for quantitative measurement of liver function: a multicentre study. Eur J Nucl Med 24:130PubMedCrossRef Ha-Kawa SK, Tanaka Y, Hasebe S et al (1997) Compartmental analysis of asialoglycoprotein receptor scintigraphy for quantitative measurement of liver function: a multicentre study. Eur J Nucl Med 24:130PubMedCrossRef
3.
go back to reference Kwon AH, Ha-Kawa SK, Uetsuji S et al (1997) Preoperative determination of the surgical procedure for hepatectomy using technetium-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy. Hepatology 25:426PubMedCrossRef Kwon AH, Ha-Kawa SK, Uetsuji S et al (1997) Preoperative determination of the surgical procedure for hepatectomy using technetium-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy. Hepatology 25:426PubMedCrossRef
4.
go back to reference Kwon AH, Ha-Kawa SK, Uetsuji S et al (1995) Use of technetium 99m diethylenetriaminepentaacetic acid-galactosyl-human serum albumin liver scintigraphy in the evaluation of preoperative and postoperative hepatic functional reserve for hepatectomy. Surgery 117:429PubMedCrossRef Kwon AH, Ha-Kawa SK, Uetsuji S et al (1995) Use of technetium 99m diethylenetriaminepentaacetic acid-galactosyl-human serum albumin liver scintigraphy in the evaluation of preoperative and postoperative hepatic functional reserve for hepatectomy. Surgery 117:429PubMedCrossRef
5.
go back to reference Kudo M, Todo A, Ikekubo K et al (1991) Functional hepatic imaging with receptor-binding radiopharmaceutical: clinical potential as a measure of functioning hepatocyte mass. Gastroenterol Jpn 26:734PubMed Kudo M, Todo A, Ikekubo K et al (1991) Functional hepatic imaging with receptor-binding radiopharmaceutical: clinical potential as a measure of functioning hepatocyte mass. Gastroenterol Jpn 26:734PubMed
6.
go back to reference Wu J, Ishikawa N, Takeda T et al (1995) The functional hepatic volume assessed by 99mTc-GSA hepatic scintigraphy. Ann Nucl Med 9:229PubMedCrossRef Wu J, Ishikawa N, Takeda T et al (1995) The functional hepatic volume assessed by 99mTc-GSA hepatic scintigraphy. Ann Nucl Med 9:229PubMedCrossRef
7.
go back to reference Ota T, Seki M, Morita R (1997) Case report: focal fatty infiltration of the liver with accumulation defect on Tc-99m colloid and Tc-99m-GSA scintigraphy. Clin Radiol 52:399PubMedCrossRef Ota T, Seki M, Morita R (1997) Case report: focal fatty infiltration of the liver with accumulation defect on Tc-99m colloid and Tc-99m-GSA scintigraphy. Clin Radiol 52:399PubMedCrossRef
8.
go back to reference Kimoto M (1996) Quantitative evaluation of 99mTc-GSA for fatty liver and ischemia reperfusion injury in rats. Nippon Igaku Hoshasen Gakkai Zasshi 56:311 (in Japanese with English abstract)PubMed Kimoto M (1996) Quantitative evaluation of 99mTc-GSA for fatty liver and ischemia reperfusion injury in rats. Nippon Igaku Hoshasen Gakkai Zasshi 56:311 (in Japanese with English abstract)PubMed
9.
go back to reference Tomiguchi S, Kira T, Oyama Y et al (1995) Correlation of Tc-99m GSA hepatic studies with biopsies in patients with chronic active hepatitis. Clin Nucl Med 20:717–720PubMedCrossRef Tomiguchi S, Kira T, Oyama Y et al (1995) Correlation of Tc-99m GSA hepatic studies with biopsies in patients with chronic active hepatitis. Clin Nucl Med 20:717–720PubMedCrossRef
10.
go back to reference Hayashi M, Fujii K, Kiuchi T et al (1999) Effects of fatty infiltration of the graft on the outcome of living-related liver transplantation. Transplant Proc 31:403PubMedCrossRef Hayashi M, Fujii K, Kiuchi T et al (1999) Effects of fatty infiltration of the graft on the outcome of living-related liver transplantation. Transplant Proc 31:403PubMedCrossRef
11.
go back to reference Ito T, Kiuchi T, Egawa H et al (2003) Surgery-related morbidity in living donors of right lobe liver graft: lessons from the first 200 cases. Transplantation 76:158PubMedCrossRef Ito T, Kiuchi T, Egawa H et al (2003) Surgery-related morbidity in living donors of right lobe liver graft: lessons from the first 200 cases. Transplantation 76:158PubMedCrossRef
12.
go back to reference Cho JY, Suh K-S, Kwon CH et al (2006) Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired. Surgery 139:508PubMedCrossRef Cho JY, Suh K-S, Kwon CH et al (2006) Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired. Surgery 139:508PubMedCrossRef
13.
go back to reference Iwasaki M, Takada Y, Hayashi M et al (2004) Noninvasive evaluation of graft steatosis in living donor liver transplantation. Transplantation 78:1501PubMedCrossRef Iwasaki M, Takada Y, Hayashi M et al (2004) Noninvasive evaluation of graft steatosis in living donor liver transplantation. Transplantation 78:1501PubMedCrossRef
14.
go back to reference Ha-Kawa SK, Suga Y, Ikeda K et al (1993) Usefulness of blood disappearance corrected hepatic uptake ratio (LHL/HH) as a hepatic functional index using 99mTc-galactosyl serum albumin. Kakuigaku 30:1333 (in Japanese with English abstract) Ha-Kawa SK, Suga Y, Ikeda K et al (1993) Usefulness of blood disappearance corrected hepatic uptake ratio (LHL/HH) as a hepatic functional index using 99mTc-galactosyl serum albumin. Kakuigaku 30:1333 (in Japanese with English abstract)
15.
go back to reference Ha-Kawa SK, Tanaka Y (1991) A quantitative model of technetium-99m-DTPA-galactosyl-HSA for the assessment of hepatic blood flow and hepatic binding receptor. J Nucl Med 32:2233PubMed Ha-Kawa SK, Tanaka Y (1991) A quantitative model of technetium-99m-DTPA-galactosyl-HSA for the assessment of hepatic blood flow and hepatic binding receptor. J Nucl Med 32:2233PubMed
16.
go back to reference Kira T, Tomiguchi S, Takahashi M et al (1999) Correlation of 99mTC-GSA hepatic scintigraphy with liver biopsies in patients with chronic active hepatitis type C. Radiat Med 17:125PubMed Kira T, Tomiguchi S, Takahashi M et al (1999) Correlation of 99mTC-GSA hepatic scintigraphy with liver biopsies in patients with chronic active hepatitis type C. Radiat Med 17:125PubMed
17.
go back to reference Kwon AH, Matsui Y, Ha-Kawa SK et al (2001) Functional hepatic volume measured by technetium-99m-galactosyl-human serum albumin liver scintigraphy: comparison between hepatocyte volume and liver volume by computed tomography. Am J Gastroenterol 96:541PubMedCrossRef Kwon AH, Matsui Y, Ha-Kawa SK et al (2001) Functional hepatic volume measured by technetium-99m-galactosyl-human serum albumin liver scintigraphy: comparison between hepatocyte volume and liver volume by computed tomography. Am J Gastroenterol 96:541PubMedCrossRef
18.
go back to reference Gartner U, Stockert RJ, Morell AG et al (1981) Modulation of the transport of bilirubin and asialoorosomucoid during liver regeneration. Hepatology 1:99PubMedCrossRef Gartner U, Stockert RJ, Morell AG et al (1981) Modulation of the transport of bilirubin and asialoorosomucoid during liver regeneration. Hepatology 1:99PubMedCrossRef
19.
go back to reference Meyer B, Luo HS, Bargetzi M et al (1991) Quantitation of intrinsic drug-metabolizing capacity in human liver biopsy specimens: support for the intact-hepatocyte theory. Hepatology 13:475PubMedCrossRef Meyer B, Luo HS, Bargetzi M et al (1991) Quantitation of intrinsic drug-metabolizing capacity in human liver biopsy specimens: support for the intact-hepatocyte theory. Hepatology 13:475PubMedCrossRef
20.
go back to reference Stockert RJ, Morell AG (1983) Hepatic binding protein: the galactose-specific receptor of mammalian hepatocytes. Hepatology 3:750PubMedCrossRef Stockert RJ, Morell AG (1983) Hepatic binding protein: the galactose-specific receptor of mammalian hepatocytes. Hepatology 3:750PubMedCrossRef
21.
go back to reference Pomfret EA, Pomposelli JJ, Gordon FD et al (2003) Liver regeneration and surgical outcome in donors of right-lobe liver grafts. Transplantation 76:5PubMedCrossRef Pomfret EA, Pomposelli JJ, Gordon FD et al (2003) Liver regeneration and surgical outcome in donors of right-lobe liver grafts. Transplantation 76:5PubMedCrossRef
22.
go back to reference Humar A, Kosari K, Sielaff TD et al (2004) Liver regeneration after adult living donor and deceased donor split-liver transplants. Liver Transpl 10:374PubMedCrossRef Humar A, Kosari K, Sielaff TD et al (2004) Liver regeneration after adult living donor and deceased donor split-liver transplants. Liver Transpl 10:374PubMedCrossRef
23.
go back to reference Selzner M, Clavien PA (2000) Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway. Hepatology 31:35PubMedCrossRef Selzner M, Clavien PA (2000) Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway. Hepatology 31:35PubMedCrossRef
24.
go back to reference Selzner M, Clavien PA (2001) Fatty liver in liver transplantation and surgery. Semin Liver Dis 21:105PubMedCrossRef Selzner M, Clavien PA (2001) Fatty liver in liver transplantation and surgery. Semin Liver Dis 21:105PubMedCrossRef
25.
go back to reference Imber CJ, St Peter SD, Handa A et al (2002) Hepatic steatosis and its relationship to transplantation. Liver Transpl 8:415PubMedCrossRef Imber CJ, St Peter SD, Handa A et al (2002) Hepatic steatosis and its relationship to transplantation. Liver Transpl 8:415PubMedCrossRef
26.
go back to reference D’Alessandro AM, Kalayoglu M, Sollinger HW et al (1991) The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation 51:157PubMed D’Alessandro AM, Kalayoglu M, Sollinger HW et al (1991) The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation 51:157PubMed
27.
go back to reference Todo S, Demetris AJ, Makowka L et al (1989) Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 47:903PubMedCrossRef Todo S, Demetris AJ, Makowka L et al (1989) Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 47:903PubMedCrossRef
28.
go back to reference Marsman WA, Weisner RH, Rodriguez L et al (1996) Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 62:1246PubMedCrossRef Marsman WA, Weisner RH, Rodriguez L et al (1996) Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 62:1246PubMedCrossRef
Metadata
Title
Liver Regeneration in Donors Evaluated by Tc-99m-GSA Scintigraphy after Living Donor Liver Transplantation
Authors
Masaki Kaibori
Sang Kil Ha-Kawa
Yoichiro Uchida
Morihiko Ishizaki
Takamichi Saito
Kosuke Matsui
Junko Hirohara
Koichi Tanaka
Yasuo Kamiyama
Publication date
01-03-2008
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 3/2008
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-007-9902-5

Other articles of this Issue 3/2008

Digestive Diseases and Sciences 3/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.